Open access · US-GOV via ClinicalTrials.gov Clinical trial

Single-Blind Study Determining the Efficacy of Polypodium Leucotomos Extract Supplement in Decreasing UVA Premutagenic and Photoaging Markers

Authors not listed

University of Miami · 2007

Dysbiosis Human Randomized controlled trial

Abstract

With this study, the investigators will like to determine if taking a dose of the study medication, called Polypodium leucotomos (PL), prevents some of the changes in the skin caused by the adverse effects of UVA, a type of ultraviolet light.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-17 MST

Cite this

APA

Anonymous. (2007). Single-Blind Study Determining the Efficacy of Polypodium Leucotomos Extract Supplement in Decreasing UVA Premutagenic and Photoaging Markers. <em>University of Miami</em>. https://clinicaltrials.gov/study/NCT00520910

Vancouver

Anonymous. Single-Blind Study Determining the Efficacy of Polypodium Leucotomos Extract Supplement in Decreasing UVA Premutagenic and Photoaging Markers. University of Miami. 2007.

BibTeX

@misc{anon2007Single, title = {Single-Blind Study Determining the Efficacy of Polypodium Leucotomos Extract Supplement in Decreasing UVA Premutagenic and Photoaging Markers}, author = {Anonymous}, journal = {University of Miami}, year = {2007}, }